ARCHIVES

Dana-Farber And Merck To Collaborate On Therapeutics.

This article is from The Cancer Letter archive.

Vol. 34 No. 06 | February 15, 2008

Download PDF Visit The Full Archive

Related Articles

Cooney to Oversee University of Michigan Clinical Operations

February 7, 2013

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

Avastin Improves PFS In Advanced Breast Cancer

April 29, 2005

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

NCI to Implement Plan For Stepped Up Patient Accrual Despite Reservations OF Group Chairmen

December 4, 1987